Lexeo Therapeutics, Inc. (LXEO) EPS (Basic) (2022 - 2023)
Lexeo Therapeutics' EPS (Basic) history spans 2 years, with the latest figure at $19.84 for Q4 2023.
- For Q4 2023, EPS (Basic) changed N/A year-over-year to $19.84; the TTM value through Dec 2023 reached -$12.4, changed N/A, while the annual FY2024 figure was -$3.09, 75.08% up from the prior year.
- EPS (Basic) for Q4 2023 was $19.84 at Lexeo Therapeutics, up from -$12.36 in the prior quarter.
- Across five years, EPS (Basic) topped out at $19.84 in Q4 2023 and bottomed at -$12.36 in Q3 2023.